Article

Ligand-based adoptive T cell targeting CA125 in ovarian cancer

2023-03-24

Abstract excerpt

<title>Abstract</title> <p>Background: Ovarian cancer (OC) is a globally malignant gynecological disease with aggressive nature, most OC cases are diagnosed at late stages and the 5-year overall survival was less than 35% after conventional treatment. Furthermore, OC patients are rarely responsive to immune-check-point inhibitor therapy, and the efficacy of CAR-T therapy was also modest due to inefficient T cell...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3e484b33-2b22-5e0f-89f6-9d9a7a015dec
DOI: 10.21203/rs.3.rs-2605996/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Ligand-based adoptive T cell targeting CA125 in ovarian cancerDOI 10.21203/rs.3.rs-2605996/v1Read

Mesothelin-Specific CAR T Cells Target Ovarian Cancer.Semantic proximity Read

Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacySemantic proximity Read

Immunotherapeutic Approaches in Ovarian CancerSemantic proximity Read

Therapeutic Effect of Dual CAR-T Targeting PDL1 and MUC16 Antigens on Ovarian Cancer Cells in MiceSemantic proximity Read

PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivoSemantic proximity Read

Engineering antigen-driven co-stimulation and T helper cell activity into TCR-T cells with CD8-41BB fusion receptors enhances anti-tumor activitySemantic proximity Read

C3AR1 promotes ovarian cancer progression and induces suppressive immunocyte infiltration: evidence from comprehensive bioinformatics analysis and experimentsSemantic proximity Read

Immunotherapy for ovarian cancer is improved by tumor-targeted delivery of a neoantigen surrogateSemantic proximity Read

Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-culturesSemantic proximity Read

Therapeutic Applications of Engineered Chimeric Antigen Receptors-T cell for Cancer TherapySemantic proximity Read

A PD-L1-targeting chimeric switch receptor enhances efficacy of CAR-T cell for pleural and peritoneal metastasisSemantic proximity Read

Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachmentSemantic proximity Read